Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Intellia Therapeutics (NTLA)
NASDAQ:NTLA
Holding NTLA?
Track your performance easily
Intellia Therapeutics (NTLA) Ownership Overview
1.74% Insiders
21.73% Mutual Funds
21.49% Other Institutional Investors
30.57% ETFs
24.47% Public Companies and Individual Investors
The ownership structure of Intellia Therapeutics (NTLA) stock is a mix of institutional, retail, and individual investors. Approximately 73.79% of the company’s stock is owned by Institutional Investors, 1.74% is owned by Insiders, and 24.47% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Oct 04, 2024 | Michael P Dube Vp & Cao | xxxxxxxxxxxxx | $38248 |
| Mar 05, 2024 | Eliana Clark Evp, Cto | xxxxxxxxxxxxx | $19959 |
| Mar 05, 2024 | James Basta Evp & Gc | xxxxxxxxxxxxx | $75778 |
| Jan 05, 2024 | Eliana Clark Evp, Cto | xxxxxxxxxxxxx | $126707 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2024 | xxxxxxxxxxxxx | $7206 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $242106 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $259513757 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 12,255,440 | Institution | 12.03% | 204,053,076 | |
| 11,558,208 | Institution | 11.35% | 192,444,163 | |
| 9,337,270 | Institution | 9.17% | 155,465,546 | |
| 7,944,720 | Institution | 7.80% | 132,279,588 | |
| 4,644,936 | Institution | 4.56% | 77,338,184 | |
| 3,089,420 | Institution | 3.03% | 51,438,843 | |
| 2,260,875 | Institution | 2.22% | 37,643,569 | |
| 1,658,211 | Institution | 1.63% | 27,609,213 | |
| 1,104,841 | Institution | 1.08% | 18,395,603 | |
| 1,046,065 | Institution | 1.03% | 17,416,982 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,944,720 | Institution | 7.80% | 132,279,588 | |
| 2,260,875 | Institution | 2.22% | 37,643,569 | |
| 1,658,211 | Institution | 1.63% | 27,609,213 | |
| 1,104,841 | Institution | 1.08% | 18,395,603 | |
| 1,046,065 | Institution | 1.03% | 17,416,982 | |
| 981,815 | Institution | 0.96% | 16,347,220 | |
| 818,179 | Institution | 0.80% | 13,622,680 | |
| 513,980 | Institution | 0.50% | 8,557,767 | |
| 499,045 | Institution | 0.49% | 8,309,099 | |
| 463,073 | Institution | 0.45% | 7,710,165 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,677,940 | Institution | 8.52% | 144,487,701 | |
| 3,171,588 | Institution | 3.11% | 65,176,133 | |
| 2,945,911 | Institution | 2.89% | 51,553,443 | |
| 3,071,853 | Institution | 3.02% | 51,146,352 | |
| 2,411,725 | Institution | 2.37% | 49,560,949 | |
| 2,677,311 | Institution | 2.63% | 44,577,228 | |
| 1,521,149 | Institution | 1.49% | 31,259,612 | |
| 1,332,207 | Institution | 1.31% | 27,376,854 | |
| 926,708 | Institution | 0.91% | 15,429,688 | |
| 703,757 | Institution | 0.69% | 11,717,554 |
FAQ
Who Owns Intellia Therapeutics (NTLA)?
According to the latest TipRanks data, approximately 21.49% of the company's stock is held by institutional investors, 1.74% is held by insiders, and 24.47% is held by retail investors.
What percentage of Intellia Therapeutics (NTLA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 21.49% of Intellia Therapeutics (NTLA) stock is held by institutional investors.
What percentage of Intellia Therapeutics (NTLA) stock is held by retail investors?
According to the latest TipRanks data, approximately 24.47% of Intellia Therapeutics (NTLA) stock is held by retail investors.
Who owns the most shares of Intellia Therapeutics (NTLA)?
Cathie Wood owns the most shares of Intellia Therapeutics (NTLA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.